JMNP/
Articles/
2509001619
  • Open Access
  • Article

The Anti-Obesity Effects of Triphala and Triphala Guggul: A Systematic Review and Meta-Analysis of Clinical Trials 

  • Arash Salehi 1,2,   
  • Sedigheh Asgary 3,*,   
  • Pardis Mohammadipour 4,   
  • Nizal Sarrafzadegan 3,5,   
  • Cesar de Oliveira 6,   
  • Erika Aparecida Silveira 6,7

Received: 27 Jun 2025 | Revised: 02 Sep 2025 | Accepted: 23 Sep 2025 | Published: 29 Sep 2025

Abstract

Background: Obesity is a progressively serious universal health problem requiring an impressive treatment alternative. Triphala and Triphala Guggul, which include Guggul resin, are traditional therapies suggested for controlling obesity. Their advantage however, has not yet been examined in depth in clinical trials. Methods: A systematic review and meta-analysis of controlled trials was run in accordance with PRISMA guidelines. Three main databases (PubMed, Scopus, and Web of Science) together with Google Scholar were searched up to July 2025. Eligibility was limited to controlled trials including overweight adults or patients with obesity that examine Triphala or Triphala Guggul in comparison with control interventions. Facts on body weight, body mass index, and other anthropometric measures were adapted. The quality of included studies was assessed using a modified Oxford Quality Score System (OQSS), and the risk of bias was evaluated using the Cochrane Risk of Bias tool. Random-effects meta-analysis was accomplished using RevMan 5.4 and Stata 17. Results: Fifteen studies (10 Triphala, 5 Triphala Guggul) with 800 contributors were included. Meta-analysis of five studies on oral Triphala administration reveals a statistically significant decline in body weight (mean difference = −2.4 kg, 95% CI: −4.2 to −0.6, p = 0.01), though with high heterogeneity (I2 = 91%). The effect on body mass index was not statistically significant (p = 0.09). Topical applications did not result in notable effects. Both formulations were well-tolerated with no serious adverse events documented, except for the infrequent occurrence of hypersensitivity skin reactions. Methodological quality was variable, with a third of the studies rated as low quality. Conclusions: Oral short term consumption of Triphala led to a reduction in body weight accross individuals with obesity, although its efficacy for body mass index remains indecisive. Topical administration did not exhibit significant profit. Oral Triphala becomes visible to be a safe complementary supplementation for obesity in a short period; however, the evidence is inconsistent due to variability in study quality and outcomes. Advanced highquality, long-term studies are required to ensure effectiveness, optimal dosing, and long-term safety. 

References 

  • 1.
    Shin, S.S.; Yoon, M. Regulation of Obesity by Antiangiogenic Herbal Medicines. Molecules 2020, 25, 4549. https://doi.org/10.3390/molecules25194549.
  • 2.
    Redinger, R.N. The Pathophysiology of Obesity and Its Clinical Manifestations. Gastroenterol. Hepatol. 2007, 3, 856–863.
  • 3.
    GBD 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med. 2017, 377, 13–27.
  • 4.
    Silveira, E.A.; Vaseghi, G.; de Santos, A.S.C.; et al. Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments. Int. J. Mol. Sci. 2020, 21, 9042. https://doi.org/10.3390/ijms21239042.
  • 5.
    Silveira, E.A.; Kliemann, N.; Noll, M.; et al. Visceral Obesity and Incident Cancer and Cardiovascular Disease: An Integrative Review of the Epidemiological Evidence. Obes. Rev. 2021, 22, e13088. https://doi.org/10.1111/obr.13088.
  • 6.
    Pasarica, M.; Dhurandhar, N.V. Infectobesity: Obesity of Infectious Origin. Adv. Food Nutr. Res. 2007, 52, 61–102.
  • 7.
    Lin, X.; Li, H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front. Endocrinol. 2021, 12, 706978. https://doi.org/10.3389/fendo.2021.706978.
  • 8.
    Singh, A.; Hardin, B.I.; Singh, D.; et al. Epidemiologic and Etiologic Considerations of Obesity; StatPearls: St. Petersburg, FL, USA, 2022.
  • 9.
    Boix-Castejón, M.; Herranz-López, M.; Gago, A.P.; et al. Hibiscus and Lemon Verbena Polyphenols Modulate Appetite-Related Biomarkers in Overweight Subjects: A Randomized Controlled Trial. Food Funct. 2018, 9, 3173–3184.
  • 10.
    Kim, J.H.; Joung, H.Y.; Kang, S.A.; et al. Ginsenoside Rb1 as a Suppressor in Central Modulation of Feeding in the Rat. Appetite 2007, 49, 303.
  • 11.
    Janssens, P.L.H.R.; Hursel, R.; Martens, E.A.P.; et al. Acute Effects of Capsaicin on Energy Expenditure and Fat Oxidation in Negative Energy Balance. PLoS ONE 2013, 8, e67786.
  • 12.
    Hursel, R.; Viechtbauer, W.; Dulloo, A.G.; et al. The Effects of Catechin Rich Teas and Caffeine on Energy Expenditure and Fat Oxidation: A Meta‐analysis. Obes. Rev. 2011, 12, e573–e581.
  • 13.
    Zhong, L.; Furne, J.K.; Levitt, M.D. An Extract of Black, Green, and Mulberry Teas Causes Malabsorption of Carbohydrate but Not of Triacylglycerol in Healthy Volunteers. Am. J. Clin. Nutr. 2006, 84, 551–555.
  • 14.
    Gupta, A.; Gupta, R.; Lal, B. Effect of Trigonella Foenum-Graecum (Fenugreek) Seeds on Glycaemic Control and Insulin Resistance in Type 2 Diabetes. J. Assoc. Physicians India 2001, 49, 1057–1061.
  • 15.
    Saito, R.; Yamada, S.; Yamamoto, Y.; et al. Conophylline Suppresses Pancreatic Stellate Cells and Improves Islet Fibrosis in Goto-Kakizaki Rats. Endocrinology 2012, 153, 621–630.
  • 16.
    Hamid, K.S.; Khalaj A.; Ranjbar, S.H.; et al. A Systematic Review of the Antioxidant, Anti-Diabetic, and Anti-Obesity Effects and Safety of Triphala Herbal Formulation. J. Med. Plants Res. 2013, 7, 831–844. https://doi.org/10.5897/JMPR12.352.
  • 17.
    Mukherjee, P.K.; Rai, S.; Bhattachar, S.; et al. Clinical Study of ‘Triphala’–A Well Known Phytomedicine from India. 2006, 5, 51–54.
  • 18.
    Upton, R.; Kumar, P. Triphala (Three Fruits), American Herbal Pharmacopoeia and Therapeutic Compendium. Available online: https://herbal-ahp.org/ahp-monographs-triphala/ (accessed on 20 June 2025).
  • 19.
    Peterson, C.T.; Denniston, K.; Chopra, D. Therapeutic Uses of Triphala in Ayurvedic Medicine. J. Altern. Complement. Med. 2017, 23, 607–614. https://doi.org/10.1089/acm.2017.0083.
  • 20.
    Joshi, M.; Khanchandani, P. A Systematic Review of Triphala Churna: A Focus on Ingredient Synergism and Its Implications for Human Health. Int. J. Sci. Res. Sci. Technol. 2024, 11, 791–800.
  • 21.
    Yearsley, C. American Herbal Pharmacopoeia Publishes Triphala Monograph and Therapeutic Compendium. HerbalGram 2021, 129, 33.
  • 22.
    Ulbricht, C.; Basch, E.; Szapary, P.; et al. Guggul for Hyperlipidemia: A Review by the Natural Standard Research Collaboration. Complement. Ther. Med. 2005, 13, 279–290. https://doi.org/10.1016/j.ctim.2005.08.003.
  • 23.
    Sarup, P.; Bala, S.; Kamboj, S. Pharmacology and Phytochemistry of Oleo-Gum Resin of Commiphora Wightii (Guggulu). Scientifica 2015, 2015, 138039. https://doi.org/10.1155/2015/138039.
  • 24.
    Donato, F.; Raffetti, E.; Toninelli, G.; et al. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. Complement. Med. Res. 2021, 28, 216–225. https://doi.org/10.1159/000510985.
  • 25.
    Chandran, U.; Mehendale, N.; Patil, S.; et al. Innovative Approaches in Drug Discovery. Innovative Approaches in Drug Discovery; Academic Press: Cambridge, MA, USA, 2017. https://doi.org/10.1016/c2014-0-00134-7.
  • 26.
    Khopde, S.M.; Priyadarsini, K.I.; Mohan, H.; et al. Characterizing the Antioxidant Activity of Amla (Phyllanthus emblica) Extract. Curr. Sci. 2001, 81, 185–190.
  • 27.
    Nisha, P.; Singhal, R.S.; Pandit, A.B. A Study on Degradation Kinetics of Ascorbic Acid in Amla (Phyllanthus emblica L.) during Cooking. Int. J. Food Sci. Nutr. 2004, 55, 415–422. https://doi.org/10.1080/09637480412331321823.
  • 28.
    Paul, D.K.; Shaha, R.K. Citrus Fruits in the Northern Region of Bangladesh. Pakistan J. Biol. Sci. 2004, 7, 238–242.
  • 29.
    Scartezzini, P.; Antognoni, F.; Raggi, M.A.; et al. Vitamin C Content and Antioxidant Activity of the Fruit and of the Ayurvedic Preparation of Emblica Officinalis Gaertn. J. Ethnopharmacol. 2006, 104, 113–118. https://doi.org/10.1016/j.jep.2005.08.065.
  • 30.
    Scartezzini, P.; Speroni, E. Review on Some Plants of Indian Traditional Medicine with Antioxidant Activity. J. Ethnopharmacol. 2000, 71, 23–43. https://doi.org/10.1016/S0378-8741(00)00213-0.
  • 31.
    Prakash, S.; Shelke, A.U. Role of Triphala in Dentistry. J. Indian Soc. Periodontol. 2014, 18, 132–135. https://doi.org/10.4103/0972-124X.131299.
  • 32.
    Pawar, V.; Lahorkar, P.; Anantha Narayana, D.B. Development of a RP-HPLC Method for Analysis of Triphala Curna and Its Applicability to Test Variations in Triphala Curna Preparations. Indian J. Pharm. Sci. 2009, 71, 382–386. https://doi.org/10.4103/0250-474X.57286.
  • 33.
    Ghosal, S.; Tripathi, V.K.; Chauhan, S. Active Constituents of Emblica Officinalis : Part 1-The Chemistry and Antioxidative Effects of Two New Hydrolysable Tannins, Emblicanin A and B. Indian J. Chem. 1996, 35, 941–948.
  • 34.
    Gulati, R.K.; Agarwal, S.; Agrawal, S.S. Hepatoprotective Studies on Phyllanthus Emblica Linn. and Quercetin. Indian J. Exp. Biol. 1995, 33, 261–268.
  • 35.
    Khanna, P.; Bansal, R. Phyllantidine and Phyllantine from Emblica Officinalis Gaertn Leaves, Fruits and in Vitro Tissue Cultures. Indian J. Exp. Biol. 1975, 13, 82–83.
  • 36.
    Ansolkar, L.V.; Kakkar, K.K.; Chakre, O.J. Second Supplement to Glossary of Indian Medicinal Plants; Publications & Information Directorate: Lodhi, New Delhi, 1992.
  • 37.
    Lee, H.S.; Koo, Y.C.; Suh, H.J.; et al. Preventive Effects of Chebulic Acid Isolated from Terminalia Chebula on Advanced Glycation Endproduct-Induced Endothelial Cell Dysfunction. J. Ethnopharmacol. 2010, 131, 567–574. https://doi.org/10.1016/j.jep.2010.07.039.
  • 38.
    Reddy, D.B.; Reddanna, P. Chebulagic Acid (CA) Attenuates LPS-Induced Inflammation by Suppressing NF-ΚB and MAPK Activation in RAW 264.7 Macrophages. Biochem. Biophys. Res. Commun. 2009, 381, 112–117. https://doi.org/10.1016/j.bbrc.2009.02.022.
  • 39.
    Chandramohan Reddy, T.; Aparoy, P.; Kishore Babu, N.; et al. Kinetics and Docking Studies of a COX-2 Inhibitor Isolated from Terminalia Bellerica Fruits. Protein Pept. Lett. 2010, 17, 1251–1257. https://doi.org/10.2174/092986610792231537.
  • 40.
    Saleem, A.; Husheem, M.; Härkönen, P.; et al. Inhibition of Cancer Cell Growth by Crude Extract and the Phenolics of Terminalia Chebula Retz. Fruit. J. Ethnopharmacol. 2002, 81, 327–336. https://doi.org/10.1016/S0378-8741(02)00099-5.
  • 41.
    Rastogi, R.P.; Mehrotra, B.N.; Sinha, S.; et al. Compendium of Indian Medicinal Plants, Volume 3. Central Drug Research Institute: Lucknow, India, 2001; Volume 1, p. 930.
  • 42.
    Rastogi, R.P.; Mehrotra, B.N.; Pastogi, R.P. Compendium of Indian Medicinal Plants; Central Drug Research Institute: Lucknow, India, 1993; Volume 2, p. 10.
  • 43.
    BN., R. and R. M. Compendium of Indian Medicinal Plants. CSIR Publ. India 1993, 3, 831.
  • 44.
    Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71.
  • 45.
    Kamali, S.H.; Khalaj, A.R.; Hasani-Ranjbar, S.; et al. Efficacy of “Itrifal Saghir”, a Combination of Three Medicinal Plants in the Treatment of Obesity; A Randomized Controlled Trial. DARU J. Pharm. Sci. 2012, 20, 33. https://doi.org/10.1186/2008-2231-20-33.
  • 46.
    Kaewtong, A.; Sugraroek, P. Effects of Triphala Formula in Obesity Stage 1 Subjects in Maharaj Nakhonsithammarat Hospital. Suthiparithat 2018, 32, 119–130.
  • 47.
    Anand, A.; Dileep, A. Open Label Three Arm Controlled on the Effect of Udvarttana and Abdominal Pack in Central Obesity. Int. J. Ayurvedic Med. 2019, 9, 243–249. https://doi.org/10.47552/ijam.v9i4.1123.
  • 48.
    Salunke, M.; Banjare, J.; Bhalerao, S. Effect of Selected Herbal Formulations on Anthropometry and Body Composition in Overweight and Obese Individuals: A Randomized, Double Blind, Placebo-Controlled Study. J. Herb. Med. 2019, 17–18, 100298. https://doi.org/10.1016/j.hermed.2019.100298.
  • 49.
    Chaitralakshmi KN, B.J. A Comparative Clinical Study to Evaluvate the Effect of Haridradi Gana Churna and Triphala Churna Udvartana in Sthoulya (Obesity). Ijapr 2019, 7, 40–45.
  • 50.
    Alam, S.M.A.M.G.M.Q.S. A Randomized Single Blind Controlled Clinical Trial on Safety and Efficacy of a Unani Formulation (Itrifal-e-Sagheer) in Dyslipidemia. Cellmed 2020, 10, 8.1–8.7.
  • 51.
    Patil, U.A. A Comparative Clinical Study of Triphaladi Taila Abhyanga and Triphala Choorna Udhvartana in the Management of Sthaulya. J. Ayurveda Integr. Med. Sci. 2018, 3, 15–22. https://doi.org/10.21760/jaims.v3i02.12081.
  • 52.
    Bijeh, N.; Korepaz Mashhadi, F.; Dareini, F. Effect of Four Weeks of Aerobic Training and Triphala Supplementation on Levels of Lipid Profile and Body Composition in Obese and Overweight Girls. J. Anim. Biol. 2019, 11, 21–34.
  • 53.
    Saroj, U.R.; Paraste, R.; Singh, B.K. Clinical evaluation of efficacy of navaka guggulu and triphala kwatha in the management of medoroga with special reference to obesity. Int. J. Ayurveda Pharma Res. 2020, 8, 59–65.
  • 54.
    Pai, S.; Shivappa, C.; Surendra, A. Anti-Obesity and Anti-Hyperlipidemic Activity of Processed Honey-A Randomised, Open Labeled, Controlled Clinical Study. J. Res. Tradit. Med. 2018, 4, 40. https://doi.org/10.5455/jrtm.2018/816.
  • 55.
    Khunt, T.; Bhatkoti, M.; Bhatt, N.N.; et al. Original research article A Comparative Clinical Study of Virechana Karma and Lekhana Basti in the Management of Sthaulya. Ayu 2012, 3, 1445–1449.
  • 56.
    Auti, S.; Thakar, A.; Shukla, V.; et al. Assessment of Lekhana Basti in the Management of Hyperlipidemia. Ayu 2013, 34, 339. https://doi.org/10.4103/0974-8520.127683.
  • 57.
    Mangal, A.; Mangal, U.; Jadhav, A.D.; et al. Effect of Triphala Guggulu and Punarnava Mandoor in the Management of Obesity: An Observational Study. Int. J. Res. Ayurveda Pharm. 2020, 11, 71–76. https://doi.org/10.7897/2277-4343.1105144.
  • 58.
    Jain Sapan, B. Clinical Evaluation of Medohar Guggul and Triphala Guggul in the Management of Obesity. Indian J. Med. Res. Pharm. Sci. 2014, 1, 14–20.
  • 59.
    Banjare, J.; Raina, P.; Mansara, P.; et al. Triphala, Regulates Adipogenesis through Modulation of Expression of Adipogenic Genes in 3T3-L1 Cell Line. Pharmacogn. Mag. 2017, 13, S834.
  • 60.
    Balusamy, S.R.; Veerappan, K.; Ranjan, A.; et al. Phyllanthus Emblica Fruit Extract Attenuates Lipid Metabolism in 3T3-L1 Adipocytes via Activating Apoptosis Mediated Cell Death. Phytomedicine 2020, 66, 153129. https://doi.org/10.1016/j.phymed.2019.153129.
  • 61.
    Gurjar, S.; Taliyan, R.; Kumari, S.; Kesharwani, P. The Interplay of Triphala and Its Constituents with Respect to Metabolic Disorders and Gut-Microbiome. Fitoterapia 2025, 106642.
  • 62.
    Barua, C.C.; Begum, S.A.; Barua, A.G.; et al. Anxiolytic and Anticonvulsant Activity of Methanol Extract of Leaves of Alternanthera brasiliana (L.) Kuntze (Amaranthaceae) in Laboratory Animals. Indian J. Exp. Biol. 2013, 51, 450–457.
  • 63.
    Park, S.K.; Lee, Y.G.; Lee, J.-I.; et al. Phyllanthus Emblica Prevents Adipogenesis by Regulating Histone Acetylation. Foods 2025, 14, 160.
  • 64.
    Kumar, N.S.; Nair, A.S.; Nair, A.M.; et al. Pharmacological and Therapeutic Effects of Triphala-A Literature Review. J. Pharmacogn. Phytochem. 2016, 5, 23.
  • 65.
    Bairwa, V.K.; Kashyap, A.K.; Meena, P.; et al. Triphala’s Characteristics and Potential Therapeutic Uses in Modern Health. Int. J. Physiol. Pathophysiol. Pharmacol. 2025, 17, 19.
  • 66.
    Panda, V.; Babar, A.; Sudhamani, S.; et al. Modulation of Satiety, Lipid Metabolism, and Insulin Sensitivity by Triphala and Garcinia Cambogia in High-Fat Diet-Induced Obese Rats. Pharmacol. Res. Nat. Prod. 2025, 7, 100234. https://doi.org/10.1016/j.prenap.2025.100234.
  • 67.
    Kwandee, P.; Somnuk, S.; Mhuantong, W.; et al. Modulation of the Fecal Microbiota and Metabolome from an Obese Adult Using a Dynamic in Vitro Human Ascending Colon Model with Triphala Extract. Food Biosci. 2025, 68, 106786. https://doi.org/10.1016/j.fbio.2025.106786.
  • 68.
    Borozan, S.; Fernandez, C.J.; Samee, A.; et al. Gut–Adipose Tissue Axis and Metabolic Health. Curr. Issues Mol. Biol. 2025, 47, 424.
  • 69.
    Singh, N.; Mahajan, S.; Subramani, S.K.; et al. Triphala Improves Glucose Homeostasis by Alleviating Atherogenic Lipids and Oxidative Stress in Human Type 2 Diabetes Mellitus. Int. Jr. Ayur. Med 2015, 6, 212–219.
  • 70.
    Kumar, V.; Singh, S.; Singh, R. Phytochemical Constituents of Guggul and Their Biological Qualities. Mini. Rev. Org. Chem. 2020, 17, 277–288.
  • 71.
    Tripathi, Y.B.; Malhotra, O.P.; Tripathi, S.N. Thyroid Stimulating Action of Z-Guggulsterone Obtained from Commiphora Mukul. Planta Med. 1984, 50, 78–80.
  • 72.
    Panda, S.; Kar, A. Gugulu (Commiphora mukul) Induces Triiodothyronine Production: Possible Involvement of Lipid Peroxidation. Life Sci. 1999, 65, PL137–PL141.
  • 73.
    Panda, S.; Kar, A. Guggulu (Commiphora mukul) Potentially Ameliorates Hypothyroidism in Female Mice. Phyther. Res. Int. J. Devoted to Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2005, 19, 78–80.
  • 74.
    Shah, A. Clinical Study to Evaluate the Efficacy of Commiphora Muku (Muqil) on Thyroid Function in Hypothyroidism. Int. J. Community Med. Public Heal. 2023, 10, 3257.
  • 75.
    Kim, J.; Ahn, D.; Chung, S.J. Chebulinic Acid Suppresses Adipogenesis in 3T3-L1 Preadipocytes by Inhibiting PPP1CB Activity. Int. J. Mol. Sci. 2022, 23, 865. https://doi.org/10.3390/ijms23020865.
  • 76.
    Feng, S.; Reuss, L.; Wang, Y. Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional Activity. Molecules 2016, 21, 1278. https://doi.org/10.3390/molecules21101278.
Share this article:
Download PDF
Supplementary Materials
DOI
10.53941/jmnp.2025.100021
Issue
Volume 2, Issue 3
How to Cite
Salehi, A.; Asgary, S.; Mohammadipour, P.; Sarrafzadegan, N.; Oliveira, C. d.; Silveira, E. A. The Anti-Obesity Effects of Triphala and Triphala Guggul: A Systematic Review and Meta-Analysis of Clinical Trials . Journal of Medicinal Natural Products 2025, 2 (3), 100021. https://doi.org/10.53941/jmnp.2025.100021.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2025 by the authors.